House Bill Would Allow Marketing of CBD Supplements

A bipartisan group of lawmakers has reintroduced legislation that would allow CBD dietary supplements to be marketed and regulated by the federal government.

H.R. 841 or the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 was introduced by Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA). It would keep the current THC limits on hemp at less than 0.3%. Hemp-derived CBD supplements would be subject to FDA regulations.

The hemp industry has grown frustrated with the FDA’s inaction on this issue. To date, only one CBD product, Epidiolex, is authorized by the FDA. It is used to treat severe forms of epilepsy.

“Reps. Schrader and Griffith have shown true leadership on this issue, and we anticipate support continuing to build as it progresses through Congress,” Jonathan Miller, General Counsel for the U.S. Hemp Roundtable, said. “The organizations working collectively to establish a trusted marketplace for ingestible hemp-derived ingredients applaud the bipartisan approach on this legislation.”